Clinical Trials : Pulmonary Fibrosis

Recruiting

Study Name: Procurement and Analysis of Specimens From Individuals With Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Date: 2004-06-09

Completed

Study Name: Dyspnea in Patients With Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Date: 2008-01-28

Completed

Study Name: Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Date: 2015-07-27
Interventions: Drug: CC-90001

Active, not recruiting

Study Name: A Study on Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells
Condition: Post-radiotherapy Pulmonary Fibrosis
Date: 2014-10-20
Interventions: Biological: clinical grade umbilical cord mesenchymal stem cells 10^6 (1 million) /Kg/person cells of cl

Completed

Study Name: Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Date: 2003-07-07
Interventions: Drug: Etanercept

Completed

Study Name: A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Condition: Pulmonary Fibrosis
Date: 2008-11-04
Interventions:

Drug: Placebo Intravenous (IV)

Completed

Study Name: Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis
Condition:

Idiopathic Pulmonary Fibrosis
Pulmonary F
Date: 2004-03-24
Interventions: Drug: Pirfenidone up to 3600 mg/day of pirfenidone given orally administered in divided doses three time

Completed

Study Name: Effect of Ambulatory Oxygen on the Walking Test in Patients With Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Date: 2016-01-22
Interventions:

Drug: oxygen information alrea

NOT_YET_RECRUITING

Study Name: Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients
Condition:
Date: 2025-11-17

Completed

Study Name: The Effect of N115 on Coughing in IPF Patients
Condition: Idiopathic Pulmonary Fibrosis
Date: 2025-11-17
Interventions: The product is a 20 mM (0.2%, 2.2 mg/mL) sodium pyruvate nasal spray in 0.9% sodium chloride with 0.02% benzalkonium chloride preservative, pH 7.

Search for Clinical Trial Results

Pulmonary Fibrosis - 51 Studies Found

Status	Study
Recruiting	Study Name: Procurement and Analysis of Specimens From Individuals With Pulmonary Fibrosis Condition: Pulmonary Fibrosis Date: 2004-06-09
Completed	Study Name: Dyspnea in Patients With Pulmonary Fibrosis Condition: Pulmonary Fibrosis Date: 2008-01-28
Completed	Study Name: Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis Condition: Pulmonary Fibrosis Date: 2015-07-27 Interventions: Drug: CC-90001
Active, not recruiting	Study Name: A Study on Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells Condition: Post-radiotherapy Pulmonary Fibrosis Date: 2014-10-20 Interventions: Biological: clinical grade umbilical cord mesenchymal stem cells 10^6 (1 million) /Kg/person cells of cl
Completed	Study Name: Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis Condition: Pulmonary Fibrosis Date: 2003-07-07 Interventions: Drug: Etanercept
Completed	Study Name: A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Condition: Pulmonary Fibrosis Date: 2008-11-04 Interventions: Drug: Placebo Intravenous (IV)
Completed	Study Name: Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Pulmonary F Date: 2004-03-24 Interventions: Drug: Pirfenidone up to 3600 mg/day of pirfenidone given orally administered in divided doses three time
Completed	Study Name: Effect of Ambulatory Oxygen on the Walking Test in Patients With Pulmonary Fibrosis Condition: Pulmonary Fibrosis Date: 2016-01-22 Interventions: Drug: oxygen information alrea
NOT_YET_RECRUITING	Study Name: Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients Condition: Date: 2025-11-17
Completed	Study Name: The Effect of N115 on Coughing in IPF Patients Condition: Idiopathic Pulmonary Fibrosis Date: 2025-11-17 Interventions: The product is a 20 mM (0.2%, 2.2 mg/mL) sodium pyruvate nasal spray in 0.9% sodium chloride with 0.02% benzalkonium chloride preservative, pH 7.